These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17898285)

  • 1. Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency.
    Su SB; Grajewski RS; Luger D; Agarwal RK; Silver PB; Tang J; Tuo J; Chan CC; Caspi RR
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4616-25. PubMed ID: 17898285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response.
    Jones LS; Rizzo LV; Agarwal RK; Tarrant TK; Chan CC; Wiggert B; Caspi RR
    J Immunol; 1997 Jun; 158(12):5997-6005. PubMed ID: 9190954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
    Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
    Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residues 1-20 of IRBP and whole IRBP elicit different uveitogenic and immunological responses in interferon gamma deficient mice.
    Avichezer D; Chan CC; Silver PB; Wiggert B; Caspi RR
    Exp Eye Res; 2000 Aug; 71(2):111-8. PubMed ID: 10930316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response.
    Wandu WS; Tan C; Ogbeifun O; Vistica BP; Shi G; Hinshaw SJ; Xie C; Chen X; Klinman DM; Cai H; Gery I
    PLoS One; 2015; 10(6):e0128906. PubMed ID: 26067490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis.
    Tarrant TK; Silver PB; Chan CC; Wiggert B; Caspi RR
    J Immunol; 1998 Jul; 161(1):122-7. PubMed ID: 9647215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
    Zhao J; Chen M; Xu H
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine production and leukocyte recruitment to the lungs of Paracoccidioides brasiliensis-infected mice is modulated by interferon-gamma.
    Souto JT; Aliberti JC; Campanelli AP; Livonesi MC; Maffei CM; Ferreira BR; Travassos LR; Martinez R; Rossi MA; Silva JS
    Am J Pathol; 2003 Aug; 163(2):583-90. PubMed ID: 12875978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response.
    Sun B; Rizzo LV; Sun SH; Chan CC; Wiggert B; Wilder RL; Caspi RR
    J Immunol; 1997 Jul; 159(2):1004-11. PubMed ID: 9218623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
    Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
    Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice.
    Keino H; Takeuchi M; Kezuka T; Yamakawa N; Tsukahara R; Usui M
    Graefes Arch Clin Exp Ophthalmol; 2003 Feb; 241(2):111-5. PubMed ID: 12605265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine production during hypersensitivity pneumonitis.
    Nance S; Cross R; Fitzpatrick E
    Eur J Immunol; 2004 Mar; 34(3):677-685. PubMed ID: 14991597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation.
    Foxman EF; Zhang M; Hurst SD; Muchamuel T; Shen D; Wawrousek EF; Chan CC; Gery I
    J Immunol; 2002 Mar; 168(5):2483-92. PubMed ID: 11859142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentially expressed genes in MHC-compatible rat strains that are susceptible or resistant to experimental autoimmune uveitis.
    Mattapallil MJ; Augello A; Cheadle C; Teichberg D; Becker KG; Chan CC; Mattapallil JJ; Pennesi G; Caspi RR
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1957-70. PubMed ID: 18281616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
    Tran EH; Prince EN; Owens T
    J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of exogenous interleukin-2, interleukin-23 on differentiation of IRBP 1-20-specific T cells toward Th1 and Th17 and comparison of the pathogenicity of IRBP 1-20-specific T cells].
    Li Y; Cui Y; Bi HS; Wang Y; Li J; Wang XR
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):224-9. PubMed ID: 23866703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.